Advanced search
Publication Cover
Scandinavian Journal of Urology Volume 52, 2018 - Issue 3
Journal homepage
906
Views
5
CrossRef citations to date
0
Altmetric
Article

Choline-phosphate cytidylyltransferase-α as a possible predictor of survival and response to cisplatin neoadjuvant chemotherapy in urothelial cancer of the bladder

Tammer HemdanDepartment of Surgical Sciences, Uppsala University, Uppsala, SwedenCorrespondence[email protected]
View further author information
,
Polat TurkerDepartment of Surgical Sciences, Uppsala University, Uppsala, SwedenView further author information
,
Per-Uno MalmströmDepartment of Surgical Sciences, Uppsala University, Uppsala, SwedenView further author information
&
Ulrika SegerstenDepartment of Surgical Sciences, Uppsala University, Uppsala, SwedenView further author information
Pages 200-205 | Received 13 Jun 2017, Accepted 30 Jan 2018, Published online: 23 Feb 2018

References

  • Grossman HB, Natale RB, Tangen CM, et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med. 2003;349:859–866.
  • Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration. Eur Urol. 2005;48:202–205.
  • Sherif A, Holmberg L, Rintala E, et al. Neoadjuvant cisplatinum based combination chemotherapy in patients with invasive bladder cancer: a combined analysis of two Nordic studies. Eur Urol. 2004;45:297–303.
  • Mullane SA, Werner L, Guancial EA, et al. Expression levels of DNA damage repair proteins are associated with overall survival in platinum-treated advanced urothelial carcinoma. Clin Genitourin Cancer. 2016;14:352–359.
  • Rahn JJ, Adair GM, Nairn RS. Multiple roles of ERCC1-XPF in mammalian interstrand crosslink repair. Environ Mol Mutagen. 2010;51:567–581.
  • Klatte T, Seitz C, Rink M, et al. ERCC1 as a prognostic and predictive biomarker for urothelial carcinoma of the bladder following radical cystectomy. J Urol. 2015;194:1456–1462.
  • European Association of Urology (EAU). European Association of Urology (EAU) 29th Annual Congress: Abstract 122. April 12, 2014.
  • Niedernhofer LJ, Bhagwat N, Wood RD. ERCC1 and non-small-cell lung cancer. N Engl J Med. 2007;356:2538–2540.
  • Bhagwat NR, Roginskaya VY, Acquafondata MB, et al. Immunodetection of DNA repair endonuclease ERCC1-XPF in human tissue. Cancer Res. 2009;69:6831–6838.
  • Sugimoto H, Banchio C, Vance DE. Transcriptional regulation of phosphatidylcholine biosynthesis. Prog Lipid Res. 2008;47:204–220.
  • Vaezi AE, Bepler G, Bhagwat NR, et al. Choline phosphate cytidylyltransferase-α is a novel antigen detected by the anti-ERCC1 antibody 8F1 with biomarker value in patients with lung and head and neck squamous cell carcinomas. Cancer. 2014;120:1898–1907.
  • Segersten MU, Edlund EK, Micke P, et al. A novel strategy based on histological protein profiling in-silico for identifying potential biomarkers in urinary bladder cancer. BJU Int. 2009;104:1780–1785.
  • Polley MY, Freidlin B, Korn EL, et al. Statistical and practical considerations for clinical evaluation of predictive biomarkers. J Natl Cancer Inst. 2013;105:1677–1683.
  • Anagnostou VK, Welsh AW, Giltnane JM, et al. Analytic variability in immunohistochemistry biomarker studies. Cancer Epidemiol Biomarkers Prev. 2010;19:982–991.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.